Does TOFACITINIB Cause Decreased appetite? 2,313 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 2,313 reports of Decreased appetite have been filed in association with TOFACITINIB (XELJANZ XR). This represents 1.5% of all adverse event reports for TOFACITINIB.
2,313
Reports of Decreased appetite with TOFACITINIB
1.5%
of all TOFACITINIB reports
1,094
Deaths
1,257
Hospitalizations
How Dangerous Is Decreased appetite From TOFACITINIB?
Of the 2,313 reports, 1,094 (47.3%) resulted in death, 1,257 (54.3%) required hospitalization, and 1,161 (50.2%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 2,313 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which TOFACITINIB Alternatives Have Lower Decreased appetite Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN